# Colistin Nephrotoxicity and Role of Alpha Lipoic Acid

> **NCT07668141** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Helwan University** · enrollment: 88 (estimated)

## Conditions studied

- Nephrotoxicity

## Interventions

- **DRUG:** alpha lipoic acid drug (thioctic acid acid)

## Key facts

- **NCT ID:** NCT07668141
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2027-01-30
- **Final completion:** 2027-02-28
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668141, "Colistin Nephrotoxicity and Role of Alpha Lipoic Acid". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*